期刊文献+

吲哚菁绿在进展期胃癌腹腔镜手术中的安全性和有效性 被引量:4

Feasibility and efficacy of indocyanine green used in laparoscopic gastrectomy for advanced gastric cancer patients
原文传递
导出
摘要 目的研究吲哚菁绿(ICG)在进展期胃癌腹腔镜手术中的安全性和有效性。方法回顾性分析中国医学科学院肿瘤医院胰胃外科2018年12月至2019年8月收治的82例临床分期为进展期行腹腔镜根治性切除术胃癌患者的资料,分为ICG组(38例)和常规手术组(44例)。对比两组患者的淋巴结清扫个数、手术时间、术中出血量、术后排气时间、发热时间、住院时间和并发症发生情况。结果ICG组和常规手术组患者的手术时间分别为(172.8±45.8)min和(162.6±45.7)min,术中出血量分别为(80.1±91.9)ml和(78.6±89.8)ml,术后住院时间分别为(7.0±2.0)d和(7.5±2.4)d,术后发热时间分别为(2.3±1.2)d和(2.9±1.9)d,术后排气时间分别为(3.4±0.8)d和(3.4±1.1)d,术后并发症的发生率分别为5.3%(2/38)和9.1%(4/44),差异均无统计学意义(均P>0.05)。ICG组患者的淋巴结清扫数为46.5枚,较常规手术组(33.0枚)增加(P=0.005)。结论ICG在进展期胃癌患者的腹腔镜手术中应用安全可靠,可能增加区域淋巴结的清扫数量。 Objective To identify the feasibility and efficacy of indocyanine green(ICG)used in laparoscopic gastrectomy for advanced gastric cancer patients.Methods From December 2018 to August 2019,the clinical data of 82 patients preoperatively diagnosed as advanced gastric cancer undergoing laparoscopic radical gastrectomy were retrospectively analyzed.These patients were divided into ICG group(n=38)and a historical control group(non-ICG group,n=44).The number of retrieved lymph nodes,operation time,blood loss,hospital stay,fever time,evacuation time and complications were compared between these two groups.Results The operation time[(172.8±45.8)min vs(162.6±45.7)min],blood loss[(80.1±91.9)ml vs(78.6±89.8)ml],hospital stay[(7.0±2.0)d vs(7.5±2.4)d],fever time[(2.3±1.2)d vs(2.9±1.9)d],evacuation time[(3.4±0.8)d vs(3.4±1.1)d]and incidence of complications(5.3%vs 9.1%)were not significantly different between the ICG and historical control groups(P>0.05).The number of retrieved lymph nodes in ICG group was significantly increased compared with that of the historical control group(46.5 vs 33.0,P=0.005).Conclusions The ICG method applied in lymph node dissection of laparoscopic radical gastrectomy is safe.Moreover,ICG might elevate the efficiency of regional lymph node dissection.
作者 马帅 解亦斌 曾红梅 徐泉 钟宇新 刘昊 马福海 赵飞 李桓 李洋 田艳涛 Ma Shuai;Xie Yibin;Zeng Hongmei;Xu Quan;Zhong Yuxin;Liu Hao;Ma Fuhai;Zhao Fei;Li Huan;Li Yang;Tian Yantao(Department of Pancreatic and Gastric Surgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Office for Cancer Registry,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;DepartmentⅡof General Surgery,Handan Central Hospital,Handan 056001,China;Department of General Surgery,North China Petroleum General Hospital,Hebei Medical University,Renqiu 062552,China)
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2019年第12期904-908,共5页 Chinese Journal of Oncology
基金 首都卫生发展科研专项(首发2018-2-4022) 北京市中医管理局专项资助(JJ2018-88)。
关键词 胃肿瘤 吲哚菁绿 淋巴结清扫 Gastric neoplasms Indocyanine green Lymphadenectomy
  • 相关文献

参考文献2

二级参考文献22

  • 1Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malig- nancies[J]. SeminOncol, 2004, 31(4):450-464.
  • 2Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of ade- nocarcinoma at the esophago-gastric junction: relevance of a topo- graphic- anatomic subclassification[J]. J Surg Oncol, 2005, 90(3): 139-146.
  • 3Kurokawa Y, Sasako M, Doki Y. Treatment approaches to esophago- gastric junction tumors[J]. Dig Surg, 2013, 30(2):169-173.
  • 4Pepek JM, Chino JP, Willett CO, et al. Preoperative chemoradiotherapy for locally advanced gastric cancer[J]. Radiat Oncol, 2013, 8:6.
  • 5Lawrence TS, Blackstock AW, McGinn C. The mechanism of action of radiosensitization of conventional chemotherapeutic agents[J]. Semin Radiat Oncol, 2003, 13(1):13-21.
  • 6van Hagen P, Hulshof MC, van lanschot J J, et al. Preoperative chemoradiotherapy for esophageal or junctionaJ cancer[J]. N Engl J Med, 2012, 366(22]:2074-2084.
  • 7Stahl M, Walz MK, Stuschke M, et al. Phase Ⅲ comparison of pre-operative chemotherapy compared with chemoradiotherapy in pa- tients with locally advanced adenocardnoma of the esophagogas- tric junction[J]. J Clin Oncol, 2009, 27(6):851-856.
  • 8Ronellenfitsch U, Schwarzbach M, Hofheinz R, et al. Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data[J]. Eur J Cancer, 2013, 49(15): 3149-3158.
  • 9Fiorica F, Di Bona D, Schepis F, et al. Preoperative chemoradiothera- py for oesophageal cancer: a systematic review and meta-analysis [J]. Gut, 2004, 53(7):925-930.
  • 10Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evalua- tion criteria in solid tumours: revised RECIST guideline (version 1.1) [J]. Eur J Cancer, 2009, 45(2):228-247.

共引文献83

同被引文献54

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部